Chemotherapy resistance in osteosarcoma: Current challenges and future directions

Alexander Ja-Ho Chou, Richard Gorlick

Research output: Contribution to journalArticle

257 Citations (Scopus)

Abstract

For patients with osteosarcoma, the use of chemotherapy has improved survival from 11% with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has since plateaued, despite advances in anticancer therapy. Elucidation of the mechanisms of chemoresistance and implementation of strategies to overcome chemoresistance will likely be pivotal to improving survival. In this review, the focus is on the current understanding of the mechanisms of resistance to the most commonly used agents in the treatment of osteosarcoma and the methods employed to overcome chemotherapy resistance.

Original languageEnglish (US)
Pages (from-to)1075-1085
Number of pages11
JournalExpert Review of Anticancer Therapy
Volume6
Issue number7
DOIs
StatePublished - Jul 2006

Fingerprint

Osteosarcoma
Drug Therapy
Survival
Therapeutics
Direction compound

Keywords

  • Chemotherapy resistance
  • Molecular mechanisms
  • Novel therapies
  • Osteosarcoma
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Chemotherapy resistance in osteosarcoma : Current challenges and future directions. / Chou, Alexander Ja-Ho; Gorlick, Richard.

In: Expert Review of Anticancer Therapy, Vol. 6, No. 7, 07.2006, p. 1075-1085.

Research output: Contribution to journalArticle

@article{5bf58059cad644e69cabe51f38899f68,
title = "Chemotherapy resistance in osteosarcoma: Current challenges and future directions",
abstract = "For patients with osteosarcoma, the use of chemotherapy has improved survival from 11{\%} with surgical resection alone in the 1960s, to 70{\%} by the mid-1980s. However, survival has since plateaued, despite advances in anticancer therapy. Elucidation of the mechanisms of chemoresistance and implementation of strategies to overcome chemoresistance will likely be pivotal to improving survival. In this review, the focus is on the current understanding of the mechanisms of resistance to the most commonly used agents in the treatment of osteosarcoma and the methods employed to overcome chemotherapy resistance.",
keywords = "Chemotherapy resistance, Molecular mechanisms, Novel therapies, Osteosarcoma, Treatment",
author = "Chou, {Alexander Ja-Ho} and Richard Gorlick",
year = "2006",
month = "7",
doi = "10.1586/14737140.6.7.1075",
language = "English (US)",
volume = "6",
pages = "1075--1085",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Chemotherapy resistance in osteosarcoma

T2 - Current challenges and future directions

AU - Chou, Alexander Ja-Ho

AU - Gorlick, Richard

PY - 2006/7

Y1 - 2006/7

N2 - For patients with osteosarcoma, the use of chemotherapy has improved survival from 11% with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has since plateaued, despite advances in anticancer therapy. Elucidation of the mechanisms of chemoresistance and implementation of strategies to overcome chemoresistance will likely be pivotal to improving survival. In this review, the focus is on the current understanding of the mechanisms of resistance to the most commonly used agents in the treatment of osteosarcoma and the methods employed to overcome chemotherapy resistance.

AB - For patients with osteosarcoma, the use of chemotherapy has improved survival from 11% with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has since plateaued, despite advances in anticancer therapy. Elucidation of the mechanisms of chemoresistance and implementation of strategies to overcome chemoresistance will likely be pivotal to improving survival. In this review, the focus is on the current understanding of the mechanisms of resistance to the most commonly used agents in the treatment of osteosarcoma and the methods employed to overcome chemotherapy resistance.

KW - Chemotherapy resistance

KW - Molecular mechanisms

KW - Novel therapies

KW - Osteosarcoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33746450466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746450466&partnerID=8YFLogxK

U2 - 10.1586/14737140.6.7.1075

DO - 10.1586/14737140.6.7.1075

M3 - Article

C2 - 16831079

AN - SCOPUS:33746450466

VL - 6

SP - 1075

EP - 1085

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 7

ER -